Wordt geladen...
Eye Movement Impairment Recovery in a Gaucher Patient Treated with Miglustat
In Gaucher Disease (GD) the enzyme (imiglucerase) replacement therapy (ERT) is not able to stop the progression of the neurological involvement, while the substrate reduction therapy (SRT), performed by N-Butyldeoxynojirimycin (miglustat), is an alternative that should be evaluated. Two sisters, pre...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2989716/ https://ncbi.nlm.nih.gov/pubmed/21152212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/358534 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|